Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial

European Journal of Neurology ◽

10.1111/j.1468-1331.2009.02534.x ◽

2009 ◽

Vol 16 (5) ◽

pp. 569-575 ◽

Author(s):

X. Liu ◽

J. Xia ◽

L. Wang ◽

Y. Song ◽

J. Yang ◽

...

Keyword(s):

Ischaemic Stroke ◽

Phase Ii ◽

Acute Ischaemic Stroke ◽

Multicenter Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial

European Journal of Neurology ◽

10.1111/j.1468-1331.2011.03634.x ◽

2012 ◽

Vol 19 (6) ◽

pp. 855-863 ◽

Author(s):

X. Liu ◽

L. Wang ◽

A. Wen ◽

J. Yang ◽

Y. Yan ◽

...

Keyword(s):

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Multicenter Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

A phase II randomized, double-blind, placebo-controlled multicenter trial evaluating the efficacy and safety of enzalutamide in combination with exemestane in estrogen or progesterone receptor-positive and HER2-normal advanced breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps653 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS653-TPS653

Author(s):

Denise A. Yardley ◽

Ahmad Awada ◽

Javier Cortes ◽

Howard A. Burris ◽

Amy C. Peterson ◽

...

Keyword(s):

Breast Cancer ◽

Progesterone Receptor ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Multicenter Trial ◽

Advanced Breast ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail

British Journal of Dermatology ◽

10.1111/bjd.19224 ◽

2020 ◽

Author(s):

B. Elewski ◽

S. Brand ◽

T. Degenhardt ◽

S. Curelop ◽

R. Pollak ◽

...

Keyword(s):

Phase Ii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Efficacy and Safety of Lebrikizumab in Severe Uncontrolled Asthma: Results from the Lute and Verse Phase II Randomized, Double-Blind, Placebo-Controlled Trials

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2013.12.1064 ◽

2014 ◽

Vol 133 (2) ◽

pp. AB402 ◽

Author(s):

Nicola A. Hanania ◽

Michael J. Noonan ◽

Jonathan Corren ◽

Phillip Korenblat ◽

Yanan Zheng ◽

...

Keyword(s):

Phase Ii ◽

Controlled Trials ◽

Efficacy And Safety ◽

Uncontrolled Asthma ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of Additional 200-mg Dose of Celecoxib in Adult Patients With Postoperative Pain Following Extraction of Impacted Third Mandibular Molar: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Japan

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.01.004 ◽

2012 ◽

Vol 34 (2) ◽

pp. 314-328 ◽

Author(s):

Ken‘ichi Saito ◽

Akihiro Kaneko ◽

Katsuyuki Machii ◽

Hiroyoshi Ohta ◽

Masayuki Ohkura ◽

...

Keyword(s):

Postoperative Pain ◽

Phase Ii ◽

Phase Ii Study ◽

Adult Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Mandibular Molar

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-1558 ◽

2017 ◽

Vol 24 (2) ◽

pp. 316-325 ◽

Author(s):

Axel Grothey ◽

Jonathan R. Strosberg ◽

Lindsay A. Renfro ◽

Herbert I. Hurwitz ◽

John L. Marshall ◽

...

Keyword(s):

Colorectal Cancer ◽

Supportive Care ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Best Supportive Care ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

10.1016/s0140-6736(20)30258-0 ◽

2020 ◽

Vol 395 (10227) ◽

pp. 878-887 ◽

Author(s):

Michael D Hill ◽

Mayank Goyal ◽

Bijoy K Menon ◽

Raul G Nogueira ◽

Ryan A McTaggart ◽

...

Keyword(s):

Randomised Controlled Trial ◽

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Randomised Controlled

Download Full-text

Poster 50: Efficacy and Safety of NT 201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) for the Treatment of Blepharospasm: Results of a Double-blind, Placebo-controlled, Randomized, Multicenter Trial

PM&R ◽

10.1016/j.pmrj.2010.07.081 ◽

2010 ◽

Vol 2 ◽

pp. S29-S30

Author(s):

Susanne Grafe ◽

Joseph Jankovic ◽

Angelika Hanschmann

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Multicenter Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Botulinum Neurotoxin Type A ◽

Complexing Proteins ◽

Download Full-text

A Double-Blind, Placebo-Controlled, Randomized Trial to Evaluate the Safety and Efficacy of Cerebrolysin in Patients with Acute Ischaemic Stroke in Asia – CASTA

International Journal of Stroke ◽

10.1111/j.1747-4949.2009.00340.x ◽

2009 ◽

Vol 4 (5) ◽

pp. 406-412 ◽

Author(s):

Z. Hong ◽

H. Moessler ◽

N. Bornstein ◽

M. Brainin ◽

W.-D. Heiss

Keyword(s):

Ischaemic Stroke ◽

Randomized Trial ◽

Acute Ischaemic Stroke ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2012.04716.x ◽

2012 ◽

Vol 27 (3) ◽

pp. e376-e383 ◽

Author(s):

K.A. Papp ◽

R. Kaufmann ◽

D. Thaçi ◽

C. Hu ◽

D. Sutherland ◽

...

Keyword(s):

Phase Ii ◽

Plaque Psoriasis ◽

Comparison Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Severe Plaque Psoriasis ◽

Dose Comparison ◽

Download Full-text